瑞普生物
(300119)
| 流通市值：59.46亿 | | | 总市值：82.69亿 |
| 流通股本：3.35亿 | | | 总股本：4.66亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 347,965,744.03 | 387,177,438.27 | 617,353,461.88 | 335,400,774.94 |
| 应收票据及应收账款 | 1,068,442,700.92 | 1,026,128,413 | 965,452,181.89 | 955,689,671.03 |
| 其中：应收票据 | 35,690,521.7 | 33,223,385.96 | 23,112,996.35 | 12,808,002.77 |
| 应收账款 | 1,032,752,179.22 | 992,905,027.04 | 942,339,185.54 | 942,881,668.26 |
| 应收款项融资 | 1,871,292.15 | 15,206,575.66 | 2,991,208 | 3,957,366.4 |
| 预付款项 | 43,369,078.33 | 39,935,693.26 | 31,704,696.11 | 31,506,353.68 |
| 其他应收款合计 | 65,781,801.36 | 63,054,999.75 | 50,939,480.03 | 46,558,192.72 |
| 其中:应收利息 | 964,416.66 | 876,652.78 | 789,874.92 | 700,138.82 |
| 存货 | 390,213,709.48 | 393,581,454.02 | 392,765,658.46 | 389,931,740.06 |
| 其他流动资产 | 88,308,108.54 | 17,348,073.2 | 74,788,573.35 | 216,881,122 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,348,371,664.99 | 3,074,979,408.23 | 3,378,521,402.17 | 3,263,327,707.08 |
| 非流动资产: | | | | |
| 长期股权投资 | 457,374,613.02 | 458,463,831.48 | 456,856,986.88 | 453,445,601.11 |
| 其他非流动金融资产 | 626,771,869.94 | 626,562,102.41 | 625,827,805.87 | 622,875,093.53 |
| 投资性房地产 | 38,461,347.41 | 39,459,574.5 | 40,457,801.57 | 41,456,028.66 |
| 固定资产 | 1,810,808,671.14 | 1,834,582,521.35 | 1,517,264,333.65 | 1,547,429,333.23 |
| 在建工程 | 101,693,464.75 | 100,758,393.74 | 98,029,064.93 | 87,830,567.96 |
| 使用权资产 | 12,505,151.49 | 14,508,358.83 | 16,511,566.17 | 18,514,773.51 |
| 无形资产 | 497,418,936.32 | 505,617,997.23 | 277,141,327.33 | 238,339,326.62 |
| 开发支出 | 181,978,059.49 | 175,409,588.81 | 142,015,206.37 | 180,366,955.61 |
| 商誉 | 312,238,524.11 | 312,238,524.11 | 67,802,743.36 | 67,802,743.36 |
| 长期待摊费用 | 329,685.76 | 235,829.69 | 320,973.62 | 406,117.55 |
| 递延所得税资产 | 22,450,744.22 | 20,213,037.06 | 14,023,939.82 | 12,262,839.72 |
| 其他非流动资产 | 25,381,877.26 | 32,807,746.26 | 29,707,023.05 | 61,884,413.14 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,087,412,944.91 | 4,120,857,505.47 | 3,285,958,772.62 | 3,332,613,794 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 7,435,784,609.9 | 7,195,836,913.7 | 6,664,480,174.79 | 6,595,941,501.08 |
| 流动负债: | | | | |
| 短期借款 | 688,293,806.34 | 696,398,714.67 | 479,655,158.4 | 533,832,311.73 |
| 应付票据及应付账款 | 472,272,042.63 | 467,811,524.1 | 546,988,679.2 | 561,973,835.63 |
| 其中：应付票据 | 120,580,395.2 | 114,971,474.1 | 216,528,456.5 | 189,591,484.8 |
| 应付账款 | 351,691,647.43 | 352,840,050 | 330,460,222.7 | 372,382,350.83 |
| 预收款项 | 124,256.04 | 88,969.03 | 86,799.29 | 84,000.88 |
| 合同负债 | 36,367,202.67 | 52,530,762.55 | 15,452,913.85 | 16,459,352.1 |
| 应付职工薪酬 | 31,107,277.12 | 31,152,494.97 | 29,738,775.3 | 60,066,462.78 |
| 应交税费 | 37,107,803.15 | 28,432,954.21 | 17,614,996.34 | 30,121,543.63 |
| 其他应付款合计 | 405,047,346.52 | 373,867,760.64 | 97,879,372.6 | 107,612,345.11 |
| 应付股利 | 35,727,106.19 | 13,622,000 | 11,822,000 | 12,344,000 |
| 一年内到期的非流动负债 | 36,927,605.14 | 27,211,988.24 | 23,575,525.27 | 22,269,214.27 |
| 其他流动负债 | 34,058,827.79 | 26,190,502.98 | 19,812,594.95 | 12,486,327.24 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,741,306,167.4 | 1,703,685,671.39 | 1,230,804,815.2 | 1,344,905,393.37 |
| 非流动负债: | | | | |
| 长期借款 | 548,818,610.41 | 424,516,701.86 | 401,913,703.86 | 307,114,925.87 |
| 租赁负债 | 717,811.51 | 4,692,493.75 | 8,839,827.31 | 8,858,502.76 |
| 递延收益 | 61,909,605.66 | 57,192,061.48 | 53,633,405.53 | 53,543,906.4 |
| 递延所得税负债 | 125,184,738.09 | 122,776,335.6 | 84,342,039.14 | 76,632,845.01 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 736,630,765.67 | 609,177,592.69 | 548,728,975.84 | 446,150,180.04 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,477,936,933.07 | 2,312,863,264.08 | 1,779,533,791.04 | 1,791,055,573.41 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 465,847,906 | 466,276,186 | 466,276,186 | 466,276,186 |
| 资本公积 | 2,190,777,091.49 | 2,193,919,637.48 | 2,195,294,925.35 | 2,193,668,540.36 |
| 减:库存股 | 71,887,282.66 | 76,063,012.66 | 84,154,732.66 | 69,084,121.08 |
| 盈余公积 | 232,291,974.82 | 232,291,974.82 | 232,291,974.82 | 232,291,974.82 |
| 未分配利润 | 1,732,853,419.99 | 1,647,256,274.43 | 1,760,722,641.08 | 1,673,151,533.16 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,549,883,109.64 | 4,463,681,060.07 | 4,570,430,994.59 | 4,496,304,113.26 |
| 少数股东权益 | 407,964,567.19 | 419,292,589.55 | 314,515,389.16 | 308,581,814.41 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,957,847,676.83 | 4,882,973,649.62 | 4,884,946,383.75 | 4,804,885,927.67 |
| 负债和股东权益合计 | 7,435,784,609.9 | 7,195,836,913.7 | 6,664,480,174.79 | 6,595,941,501.08 |
| 公告日期 | 2024-10-30 | 2024-08-24 | 2024-04-26 | 2024-03-30 |
| 审计意见(境内) | | | | 标准无保留意见 |